Surrozen (SRZN) Other Working Capital Changes (2020 - 2026)
Surrozen (SRZN) recorded quarterly Other Working Capital Changes of -$67000.0 in Q1 2026, down 144.97% quarter-over-quarter from $149000.0 in Q4 2025, and up 86.63% on a YoY basis from -$35900.5 in Q1 2025.
Surrozen (SRZN) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Surrozen's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$67000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 86.63% year-over-year to -$67000.0; the TTM figure through Mar 2026 stood at -$911000.0 (up 59.8% YoY), while the FY2025 annual figure was $32000.0, up 319900.0% from the prior year.
- Other Working Capital Changes was -$67000.0 for Q1 2026 at Surrozen, down from $149000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $297000.0 in Q3 2023 to a low of -$1.3 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$124879.6 across 5 years, with a median of $12.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes surged 2744344.44% in 2023, then plunged 500100.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$514000.0 in 2022, then slumped by 146.69% to -$1.3 million in 2023, then soared by 61.2% to -$492000.0 in 2024, then surged by 130.28% to $149000.0 in 2025, then plunged by 144.97% to -$67000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$67000.0 (Q1 2026), $149000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,000.00 |
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -501,000.00 |
| Mar 31, 2025 | -501,000.00 |
| Dec 31, 2024 | -492,000.00 |
| Dec 31, 2024 | -492,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -1.27 Mn |
| Dec 31, 2023 | -1.27 Mn |